ArticleCancer immunology, immunotherapy : CII2024

Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer.

Xiuhua Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.